“…However, some undesirable characteristics, such as high toxicity, easy degradation, and low bioavailability by binding to serum proteins, mucins, and other anionic components, have impaired the clinical translation of AMPs [ 240 , 241 ]. Therefore, recently increased attention has been placed on nanogels as carriers for the delivery of AMPs to improve the antimicrobial performance [ [243] , [244] , [245] , [246] , [247] , [248] , [249] , [250] ]. The Malmsten group investigated cationic AMPs incorporated into anionic poly (ethyl acrylate- co -methacrylic acid) (MAA) nanogels in different ways that influenced the encapsulation efficiency and release of AMPs, and the membrane interactions and antimicrobial effects of those nanogels.…”